In short
China's 2025 ADHD guideline covers the full pathway: prevalence and comorbidity, how diagnosis is made across home and school settings, why behavioural treatment comes first in preschool children, and how medication is titrated in older children.
What this guide covers: What drives it · How it looks at different ages · Making the diagnosis · Treatment: age determines the sequence · Long-term management
Attention deficit hyperactivity disorder is the commonest neurodevelopmental disorder of childhood. Around 5 percent of children worldwide meet criteria, and Chinese community surveys put the figure for 6 to 16 year-olds at roughly 6 percent. It is not a behaviour problem that children grow out of quietly: symptoms persist into adolescence in about half to two-thirds of cases, and adult prevalence is around 2.5 to 3 percent.
China's 2025 guideline on ADHD prevention and treatment sets out the whole pathway, from screening to long-term management.
What drives it
Heritability is high, estimated at 70 to 80 percent, with first-degree relatives at substantially elevated risk. Genome-wide studies implicate genes involved in dopamine and noradrenaline signalling, including DRD4, DRD5 and the dopamine transporter gene. Brain imaging consistently shows reduced volume and altered connectivity in prefrontal cortex, striatum and cerebellum — the circuits that support executive function, reward and motor control. Environmental contributors include prenatal smoking and alcohol exposure, prematurity, low birth weight, and later, family conflict, lead exposure, sleep deprivation and excessive screen time.
How it looks at different ages
Preschool children mostly show hyperactivity and impulsivity — unable to follow nursery rules, frequent temper outbursts, sometimes aggression. School-age children show the inattention clearly: cannot stay seated, loses things, makes careless errors, cannot organise work, talks excessively, interrupts. The homework battle is the classic presentation.
In adolescence the overt hyperactivity fades but inattention and poor impulse control persist, and the risks shift toward dangerous driving, substance use, school failure and mood problems. In adults, the picture is distractibility, poor organisation and time management, underperformance at work, relationship conflict and emotional volatility.
Girls more often present with the inattentive form, are quieter, and are diagnosed later and less often. Comorbidity is the rule rather than the exception: learning disorders, anxiety, depression, oppositional defiant disorder, conduct disorder, tic disorders and sleep problems.
Making the diagnosis
Diagnosis follows DSM-5 or ICD-11 criteria: a persistent pattern of inattention and/or hyperactivity-impulsivity that is inconsistent with developmental level, present for at least six months, onset before age 12, evident in two or more settings, and causing clear functional impairment. Other explanations — anxiety, autism spectrum disorder, sleep disorder, thyroid disease, hearing or vision problems — must be excluded.
The process is multi-informant. Screening tools such as the CBCL and Conners parent and teacher rating scales identify children needing assessment; the Vanderbilt and SNAP-IV scales capture both core symptoms and common comorbidities. A diagnosis should never rest on a single questionnaire completed by one adult.
Treatment: age determines the sequence
For children aged 4 to 6, behavioural treatment is first line. Parent training is the core — clear rules, consistent consequences, effective instruction-giving — supported by structured routines and reduced environmental distraction. Medication is generally not recommended at this age unless symptoms are severe and functionally disabling.
From age 6 upward, combined treatment is recommended. Medication options are stimulants such as methylphenidate and non-stimulants such as atomoxetine, started at low dose and adjusted against response and tolerability, with regular monitoring of growth, blood pressure, sleep and appetite. Behavioural components expand to include a school behaviour plan, social skills training, organisation training and cognitive behavioural work for older children.
Educational support, teacher communication, adequate sleep and physical activity are part of the plan rather than optional extras, and the guideline lists early parent-child interaction, regular sleep and exercise as protective factors.
Long-term management
ADHD is managed, not cured. Review visits track symptom control, side effects, growth, academic function and mood, and treatment is adjusted over years rather than weeks. Transition to adult services matters, because impairment at work and in relationships continues even when classroom problems resolve.
Sources and further reading
One reference to a U.S. government health source (National Institutes of Health or MedlinePlus) for the medical background of this guide. It is context, not a substitute for advice from your treating doctor.
General information for international patients, not medical advice or a diagnosis. Read the medical disclaimer.





